Psychotic Experiences Are Associated With Paternal Age But Not With Delayed Fatherhood in a Large, Multinational, Community Sample.

CAPE epidemiology paternal age psychotic experiences risk factors schizotypy

Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
21 Sep 2020
Historique:
medline: 13 2 2020
pubmed: 13 2 2020
entrez: 13 2 2020
Statut: ppublish

Résumé

Advanced paternal age has been consistently associated with an increased risk of schizophrenia. It is less known if such an association also exists with subclinical/attenuated forms of psychosis. Additionally, it has been suggested that it is not paternal age per se, but rather delayed fatherhood, as a marker of a genetic liability of psychosis, that is the cause of the association. The aim of the current study was to examine whether paternal age and/or delayed fatherhood (paternity age) predict self-reported positive, negative, and/or depressive dimensions of psychosis in a large sample from the general population. The sample (N = 1465) was composed of control subjects from the 6 countries participating in the European Union Gene-Environment Interaction study. The CAPE, a self-report questionnaire, was used to measure dimensions of subclinical psychosis. Paternal age at the time of respondents' birth and age of paternity were assessed by self-report. We assessed the influence of the variables of interest (paternal age or paternity age) on CAPE scores after adjusting for potential confounders (age, gender, and ethnicity). Paternal age was positively associated with the positive dimension of the CAPE. By contrast, paternity age was not associated with any of the psychosis dimensions assessed by the CAPE. Thus, our results do not support the idea that delayed fatherhood explains the association between age of paternity and psychosis risk. Furthermore, our results provide arguments for the hypothesis of an etiologic continuum of psychosis.

Identifiants

pubmed: 32049353
pii: 5734660
doi: 10.1093/schbul/sbz142
pmc: PMC7505204
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1327-1334

Subventions

Organisme : European Community's Seventh Framework Programme

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Franck Schürhoff (F)

INSERM, U955, Translational Neuropsychiatry lab, Créteil, France.
AP-HP, DMU IMPACT, Psychiatry and Addictology Department, Mondor University Hospital, Créteil, France.
Fondation FondaMental, Créteil, France.
Univ Paris-Est Créteil, Faculté de médecine, Créteil, France.

Baptiste Pignon (B)

INSERM, U955, Translational Neuropsychiatry lab, Créteil, France.
AP-HP, DMU IMPACT, Psychiatry and Addictology Department, Mondor University Hospital, Créteil, France.
Fondation FondaMental, Créteil, France.
Univ Paris-Est Créteil, Faculté de médecine, Créteil, France.

Mohamed Lajnef (M)

INSERM, U955, Translational Neuropsychiatry lab, Créteil, France.

Romain Denis (R)

INSERM, U955, Translational Neuropsychiatry lab, Créteil, France.
AP-HP, DMU IMPACT, Psychiatry and Addictology Department, Mondor University Hospital, Créteil, France.
Fondation FondaMental, Créteil, France.
Univ Paris-Est Créteil, Faculté de médecine, Créteil, France.

Bart Rutten (B)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands.

Craig Morgan (C)

Department of Health Service and Population Research, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Robin M Murray (RM)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Marion Leboyer (M)

INSERM, U955, Translational Neuropsychiatry lab, Créteil, France.
AP-HP, DMU IMPACT, Psychiatry and Addictology Department, Mondor University Hospital, Créteil, France.
Fondation FondaMental, Créteil, France.
Univ Paris-Est Créteil, Faculté de médecine, Créteil, France.

Jim van Os (J)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Andrei Szöke (A)

INSERM, U955, Translational Neuropsychiatry lab, Créteil, France.
AP-HP, DMU IMPACT, Psychiatry and Addictology Department, Mondor University Hospital, Créteil, France.
Fondation FondaMental, Créteil, France.
Univ Paris-Est Créteil, Faculté de médecine, Créteil, France.

Classifications MeSH